Epidemiological assessment of drug-induced disease
- 1 October 2000
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 356 (9238) , 1339-1343
- https://doi.org/10.1016/s0140-6736(00)02826-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control studyThe Lancet, 1999
- Comparative Safety Evaluation of Non-narcotic AnalgesicsJournal of Clinical Epidemiology, 1998
- Evaluation of Case Reports of Aplastic Anemia Among Patients Treated with FelbamateEpilepsia, 1997
- DRUG-ASSOCIATED ANAPHYLAXIS: 20 YEARS OF REPORTING IN THE NETHERLANDS (1974-1994) AND REVIEW OF THE LITERATUREClinical and Experimental Allergy, 1996
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugsGastroenterology, 1993
- Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleedingClinical Pharmacology & Therapeutics, 1993
- Toxic Epidermal Necrolysis and Stevens-Johnson SyndromeArchives of Dermatology, 1991
- Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugsThe Lancet, 1991